1. Home
  2. CRGX vs USNA Comparison

CRGX vs USNA Comparison

Compare CRGX & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • USNA
  • Stock Information
  • Founded
  • CRGX 2021
  • USNA 1992
  • Country
  • CRGX United States
  • USNA United States
  • Employees
  • CRGX N/A
  • USNA N/A
  • Industry
  • CRGX
  • USNA Medicinal Chemicals and Botanical Products
  • Sector
  • CRGX
  • USNA Health Care
  • Exchange
  • CRGX Nasdaq
  • USNA Nasdaq
  • Market Cap
  • CRGX 190.0M
  • USNA 565.2M
  • IPO Year
  • CRGX 2023
  • USNA 1996
  • Fundamental
  • Price
  • CRGX $4.46
  • USNA $32.77
  • Analyst Decision
  • CRGX Hold
  • USNA Hold
  • Analyst Count
  • CRGX 7
  • USNA 1
  • Target Price
  • CRGX $4.67
  • USNA $36.00
  • AVG Volume (30 Days)
  • CRGX 502.9K
  • USNA 157.7K
  • Earning Date
  • CRGX 08-11-2025
  • USNA 07-22-2025
  • Dividend Yield
  • CRGX N/A
  • USNA N/A
  • EPS Growth
  • CRGX N/A
  • USNA N/A
  • EPS
  • CRGX N/A
  • USNA 1.82
  • Revenue
  • CRGX N/A
  • USNA $876,242,000.00
  • Revenue This Year
  • CRGX $57.81
  • USNA $13.04
  • Revenue Next Year
  • CRGX N/A
  • USNA $7.36
  • P/E Ratio
  • CRGX N/A
  • USNA $18.04
  • Revenue Growth
  • CRGX N/A
  • USNA N/A
  • 52 Week Low
  • CRGX $3.00
  • USNA $23.10
  • 52 Week High
  • CRGX $25.45
  • USNA $48.85
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 57.89
  • USNA 68.33
  • Support Level
  • CRGX $4.09
  • USNA $30.36
  • Resistance Level
  • CRGX $4.51
  • USNA $31.43
  • Average True Range (ATR)
  • CRGX 0.18
  • USNA 0.82
  • MACD
  • CRGX 0.00
  • USNA 0.18
  • Stochastic Oscillator
  • CRGX 77.18
  • USNA 98.86

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Share on Social Networks: